Full View

Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID‐19: a multicenter retrospective cohort study

Z Shao, Y Feng, L Zhong, Q Xie, M Lei… - Clinical & …, 2020 - Wiley Online Library
Abstract Objective Coronavirus disease 2019 (COVID‐19) outbreak is a major challenge all
over the world, without acknowledged treatment. Intravenous immunoglobulin (IVIG) has …
被引用次数：149 相关文章
[PDF] researchgate.net

[PDF][PDF] Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID-19: a multicenter retrospective cohort study

Z Shao, Y Feng, L Zhong, Q Xie, M Lei, Z Liu, C Wang… - 2020 - researchgate.net
Abstract Objective. Coronavirus disease 2019 (COVID-19) outbreak is a major challenge all
over the world, without acknowledged treatment. Intravenous immunoglobulin(IVIG) has …

Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID‐19: a multicenter retrospective cohort study.

Z Shao, Y Feng, L Zhong, Q Xie, M Lei… - Clinical & …, 2020 - search.ebscohost.com
Abstract Objective: Coronavirus disease 2019 (COVID‐19) outbreak is a major challenge all
over the world, without acknowledged treatment. Intravenous immunoglobulin (IVIG) has …

Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID-19: a multicenter retrospective cohort study

Z Shao, Y Feng, L Zhong, Q Xie… - Clinical & …, 2020 - pubmed.ncbi.nlm.nih.gov
Objective Coronavirus disease 2019 (COVID-19) outbreak is a major challenge all over the
world, without acknowledged treatment. Intravenous immunoglobulin (IVIG) has been …
[HTML] nih.gov

[HTML][HTML] Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID‐19: a multicenter retrospective cohort study

Z Shao, Y Feng, L Zhong, Q Xie, M Lei… - Clinical & …, 2020 - ncbi.nlm.nih.gov
Objective Coronavirus disease 2019 (COVID‐19) outbreak is a major challenge all over the
world, without acknowledged treatment. Intravenous immunoglobulin (IVIG) has been …
[HTML] europepmc.org

[HTML][HTML] Clinical Efficacy of Intravenous Immunoglobulin Therapy in Critical Patients with COVID-19: A Multicenter Retrospective Cohort Study

Z Shao, Y Feng, L Zhong, Q Xie, M Lei, Z Liu, C Wang… - 2020 - europepmc.org
Clinical Efficacy of Intravenous Immunoglobulin Therapy in Critical Patients with COVID-19: A
Multicenter Retrospective Cohort Study - Abstract - Europe PMC Sign in | Create an account …

Clinical Efficacy of Intravenous Immunoglobulin Therapy in Critical Patients with COVID-19: A Multicenter Retrospective Cohort Study

Z Shao, Y Feng, L Zhong, Q Xie, M Lei, Z Liu, C Wang… - medRxiv, 2020 - medrxiv.org
Abstract Importance Coronavirus disease 2019 (COVID-19) has become pandemic, causing
more than 1.5 million infections and over ten-thousands of deaths in a short period of time …

Clinical Efficacy of Intravenous Immunoglobulin Therapy in Critical Patients with COVID-19: A Multicenter Retrospective Cohort Study

Z Shao, Y Feng, L Zhong, Q Xie, M Lei, Z Liu, C Wang… - 2020 - papers.ssrn.com
Background: Coronavirus disease 2019 (COVID-19) has become pandemic, causing more
than 1.5 million infections and over ten-thousands of deaths in a short period of time …
[PDF] scienceopen.com

[PDF][PDF] Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID-19: a multicenter retrospective cohort study

Z Shao, Y Feng, L Zhong, Q Xie, M Lei, Z Liu, C Wang… - 2020 - scienceopen.com
Abstract Objective. Coronavirus disease 2019 (COVID-19) outbreak is a major challenge all
over the world, without acknowledged treatment. Intravenous immunoglobulin(IVIG) has …

Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID‐19: a multicenter retrospective cohort study

Z Shao, Y Feng, Z Li, Q Xie, M Lei, Z Liu… - Clinical & …, 2020 - search.proquest.com
Objective Coronavirus disease 2019 (COVID‐19) outbreak is a major challenge all over the
world, without acknowledged treatment. Intravenous immunoglobulin (IVIG) has been …